Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach.
Barone A, De Prisco M, Altavilla B, Avagliano C, Balletta R, Buonaguro EF, Ciccarelli M, D'Ambrosio L, Giordano S, Latte G, Matrone M, Milandri F, Francesco DN, Vellucci L, de Bartolomeis A. Barone A, et al. Among authors: altavilla b. J Psychiatr Res. 2022 Nov;155:572-578. doi: 10.1016/j.jpsychires.2022.09.044. Epub 2022 Sep 29. J Psychiatr Res. 2022. PMID: 36206601
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
de Bartolomeis A, Prinzivalli E, Callovini G, D'Ambrosio L, Altavilla B, Avagliano C, Iasevoli F. de Bartolomeis A, et al. Among authors: altavilla b. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:356-366. doi: 10.1016/j.pnpbp.2017.09.002. Epub 2017 Sep 5. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 28887181 Clinical Trial.
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses.
Iasevoli F, Avagliano C, Altavilla B, Barone A, Ciccarelli M, D'Ambrosio L, Notar Francesco D, Razzino E, Fornaro M, de Bartolomeis A. Iasevoli F, et al. Among authors: altavilla b. Psychiatry Res. 2018 Nov;269:481-493. doi: 10.1016/j.psychres.2018.08.109. Epub 2018 Aug 31. Psychiatry Res. 2018. PMID: 30195742
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia.
Iasevoli F, Razzino E, Altavilla B, Avagliano C, Barone A, Ciccarelli M, D'Ambrosio L, Matrone M, Milandri F, Notar Francesco D, Fornaro M, de Bartolomeis A. Iasevoli F, et al. Among authors: altavilla b. Early Interv Psychiatry. 2022 Apr;16(4):352-362. doi: 10.1111/eip.13174. Epub 2021 May 16. Early Interv Psychiatry. 2022. PMID: 33998142 Free PMC article. Clinical Trial.
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs.
Iasevoli F, Avagliano C, Altavilla B, Barone A, D'Ambrosio L, Matrone M, Notar Francesco D, Razzino E, de Bartolomeis A. Iasevoli F, et al. Among authors: altavilla b. Front Psychiatry. 2018 Oct 31;9:553. doi: 10.3389/fpsyt.2018.00553. eCollection 2018. Front Psychiatry. 2018. PMID: 30429802 Free PMC article.